5th Call for proposals under IMI 2

IMI has launched its 5th Call for proposals under IMI 2.

The Call includes six topics:

  • Patient perspective elicitation on benefits and risks of medicinal products, from development through the entire life cycle, to inform the decision-making process by regulators and health technology assessment bodies      
  • Diabetic kidney disease biomarkers (DKD-BM)
  • Inflammation and AD: modulating microglia function – focussing on TREM2 and CD33
  • Understanding the role of amyloid imaging biomarkers in the current and future diagnosis and management of patients across the spectrum of cognitive impairment (from pre-dementia to dementia)   
  • Evolving models of patient engagement and access for earlier identification of Alzheimer’s disease: phased expansion study           
  • From ApoE biology to validated Alzheimer’s disease targets    

Deadline for submitting short proposals under Call 5: 13 October 2015 – 17:00 CET (Brussels time).

Find out more

The Call text, as well as details of how to apply, can be found on the Call 5 web page:


During 1-14 July 2015, IMI holds webinars on each topic of Call 5 as well as on IMI rules and procedures. For more information, to register for upcoming webinars and to download the presentations from those that have already taken place, please visit the webinar page:

Find partners for submitting a proposal

Search for project partners via the Partner Search Tool